{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-22-011475","form_type":"8-K","ticker":"TNGX","cik":"0001819133","company_name":"Tango Therapeutics, Inc.","filed_at":"2022-06-10T23:59:59+00:00","discovered_at":"2026-05-14T18:04:02.481665+00:00","generated_at":"2026-06-25T02:52:47.247279+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Tango Therapeutics shareholders elect Calhoun and Huber as Class I directors, ratify PwC as auditor","bullets":["Lesley Ann Calhoun elected with 74,549,730 votes for, 2,532,608 withheld, 4,658,458 broker non-votes.","Reid Huber elected with 74,547,606 votes for, 2,534,732 withheld, 4,658,458 broker non-votes.","PricewaterhouseCoopers ratified as independent auditor for FY2022 with 81,737,938 votes for, 400 against, 2,458 abstain.","Annual meeting held June 8, 2022; 81,740,796 shares represented (93.19% of outstanding)."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-22-011475","json":"https://secwatch.observer/filing/0000950170-22-011475.json","markdown":"https://secwatch.observer/filing/0000950170-22-011475.md","text":"https://secwatch.observer/filing/0000950170-22-011475.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1819133/000095017022011475/0000950170-22-011475-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1819133/000095017022011475/tngx-20220608.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T02:52:47.247279+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}